Cervavac Vaccine 0.5ml injection

Cervavac Vaccine 0.5ml injection is a quadrivalent Human Papillomavirus (HPV) vaccine developed by the Serum Institute of India (SII) to protect against infections caused by specific HPV types. This vaccine contains L1 virus-like particles (VLPs) from HPV types 6, 11, 16, and 18, which are responsible for a majority of cervical cancers and genital warts. It is indicated for prophylactic use in individuals aged 9 through 26 years to prevent cervical, vulvar, vaginal, and anal cancers caused by HPV types 16 and 18, as well as genital warts caused by HPV types 6 and 11.

The vaccine is administered as a 0.5ml intramuscular injection, typically into the deltoid region of the upper arm or the higher anterolateral area of the thigh. It is supplied as a ready-to-use suspension, requiring no reconstitution. Cervavac must be stored refrigerated at +2°C to +8°C and should not be frozen to maintain its efficacy.

Key Features : 

Targets Human Papillomavirus (HPV) types 6, 11, 16, and 18 for comprehensive protection.
Approved for the prevention of cervical, vulvar, vaginal, and anal cancers caused by HPV types 16 and 18.
Prevents genital warts (condyloma acuminata) caused by HPV types 6 and 11.
Recommended for girls and women, and boys and men aged 9 through 26 years.
Requires cold-chain storage between +2°C and +8°C; must not be frozen.
Administered via intramuscular injection.
Dosing schedule varies by age: 2 doses for ages 9-14 years (0 and 6 months), and 3 doses for ages 15-26 years (0, 2, and 6 months).
Nationally licensed in India by the Drugs Controller General of India (DGCI).

Cervavac Vaccine contains purified virus-like particles (VLPs) derived from the L1 protein of HPV types 6, 11, 16, and 18. These VLPs are non-infectious and help trigger the immune system to develop protective antibodies without causing disease. Cervavac does not contain live virus, ensuring it cannot cause HPV infection, making it safe and effective for the target age group.

This is an intramuscular injection (site of administration for this drug is muscle; most administered to deltoid muscle i.e. upper arm).

Step 1: Locate & Clean 2-inch area around the site with alcohol swab or pad.

Step 2: Prepare and plunge-in the drug into syringe from the vial.

Step 3: Insert the needle & plunge-out at a 90° angle to the skin with a quick thrust.

Step 4: Withdraw the needle at the same angle & press a cotton ball over site.

NOTE: Do not self-administer. It is intended to be used by healthcare professionals only.

• Any allergic reactions or injection site discomfort should be reported immediately. 

• It should only be taken under prescription. 

• Avoid use if you have had previous severe immunological reactions.

• Monitoring patients post-administration is advisable to prevent risks.

• Pregnant and breastfeeding mothers should avoid use.

• Always store capsules in a cool, dry place away from direct light.